M.A. Bray

4.6k total citations · 1 hit paper
42 papers, 3.8k citations indexed

About

M.A. Bray is a scholar working on Pharmacology, Immunology and Physiology. According to data from OpenAlex, M.A. Bray has authored 42 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 17 papers in Immunology and 11 papers in Physiology. Recurrent topics in M.A. Bray's work include Inflammatory mediators and NSAID effects (20 papers), Asthma and respiratory diseases (10 papers) and Estrogen and related hormone effects (7 papers). M.A. Bray is often cited by papers focused on Inflammatory mediators and NSAID effects (20 papers), Asthma and respiratory diseases (10 papers) and Estrogen and related hormone effects (7 papers). M.A. Bray collaborates with scholars based in United Kingdom, Switzerland and United States. M.A. Bray's co-authors include A. W. Ford‐Hutchinson, M. J. H. Smith, Michael Shipley, Mira Doig, Duncan A. Gordon, John E. Morley, F.M. Cunningham, R. W. Jones, D.H. Nugteren and D. A. van Dorp and has published in prestigious journals such as Nature, Journal of Clinical Oncology and The Journal of Infectious Diseases.

In The Last Decade

M.A. Bray

39 papers receiving 3.4k citations

Hit Papers

Leukotriene B, a potent chemokinetic and aggregating subs... 1980 2026 1995 2010 1980 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Bray United Kingdom 20 1.3k 1.2k 1.1k 717 498 42 3.8k
G.A. Higgs United Kingdom 31 698 0.5× 1.6k 1.4× 732 0.6× 877 1.2× 583 1.2× 58 4.0k
A. W. Ford‐Hutchinson Canada 33 1.4k 1.1× 1.5k 1.3× 2.3k 2.0× 1.3k 1.9× 733 1.5× 102 5.8k
Anthony W. Ford‐Hutchinson Canada 24 508 0.4× 1.3k 1.1× 1.0k 0.9× 1.1k 1.5× 478 1.0× 53 3.4k
B.B. Vargaftig France 36 1.0k 0.8× 491 0.4× 1.8k 1.6× 809 1.1× 227 0.5× 152 4.2k
Marc E. Goldyne United States 24 421 0.3× 1.0k 0.9× 546 0.5× 740 1.0× 432 0.9× 45 2.7k
Mariano Sánchez Crespo Spain 38 1.3k 1.0× 316 0.3× 481 0.4× 1.4k 2.0× 266 0.5× 140 4.0k
Patrice E. Poubelle Canada 36 1.4k 1.1× 344 0.3× 566 0.5× 1.6k 2.2× 178 0.4× 110 3.7k
Peter Vadas Canada 39 1.0k 0.8× 658 0.6× 869 0.8× 2.2k 3.1× 161 0.3× 138 5.7k
Sônia Jancar Brazil 35 1.1k 0.9× 347 0.3× 771 0.7× 912 1.3× 154 0.3× 172 3.7k
Bernd W. Spur United States 37 1.2k 1.0× 653 0.6× 2.0k 1.7× 1.1k 1.5× 1.2k 2.4× 123 5.6k

Countries citing papers authored by M.A. Bray

Since Specialization
Citations

This map shows the geographic impact of M.A. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Bray more than expected).

Fields of papers citing papers by M.A. Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Bray. The network helps show where M.A. Bray may publish in the future.

Co-authorship network of co-authors of M.A. Bray

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Bray. A scholar is included among the top collaborators of M.A. Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Bray. M.A. Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garric, Jeanne, et al.. (1995). Influence of the Sample Preservation Mode to Assess the Chronic Toxicity of an Industrial Effluent. Ecotoxicology and Environmental Safety. 30(1). 54–62. 19 indexed citations
2.
Gerspacher, Marc, et al.. (1993). Strategies in the design of peptidoleukotriene antagonists.. PubMed. 6(1-3). 265–73. 5 indexed citations
3.
Kadurugamuwa, Jagath L., B. Hengstler, M.A. Bray, & O. Zák. (1989). Inhibition of Complement-Factor-5a-Induced Inflammatory Reactions by Prostaglandin E2 in Experimental Meningitis. The Journal of Infectious Diseases. 160(4). 715–719. 30 indexed citations
4.
Anderson, Wayne H., et al.. (1989). Leukotriene D4 (LTD4) antagonists: structure activity relationships of stable phenylsubstituted leukotriene analogs.. PubMed. 19. 647–50. 1 indexed citations
5.
Bray, M.A.. (1986). Leukotrienes in inflammation. Inflammation Research. 19(1-2). 87–99. 91 indexed citations
6.
Bray, M.A.. (1984). The leukotrienes: Chemistry and biology. Immunology Today. 5(12). 367–368. 40 indexed citations
7.
Cunningham, Fiona, et al.. (1981). Aggregation of polymorphonuclear leucocytes (PMNs) by leukotriene B4: Effects of cyclooxygenase products and metabolic inhibitors. Inflammation Research. 11(6-7). 583–584. 5 indexed citations
8.
Ford‐Hutchinson, A W, M. J. H. Smith, & M.A. Bray. (1981). Leukotriene B4 (isomer III): biological activities of synthethic and biologically derived preparations. Journal of Pharmacy and Pharmacology. 33(1). 332–332. 4 indexed citations
9.
Bray, M.A., F.M. Cunningham, A. W. Ford‐Hutchinson, & M. J. H. Smith. (1981). LEUKOTRIENE B4: A MEDIATOR OF VASCULAR PERMEABILITY. British Journal of Pharmacology. 72(3). 483–486. 194 indexed citations
10.
Bray, M.A., et al.. (1981). Prostaglandin generation by separated human blood mononuclear cell fractions. International Journal of Immunopharmacology. 3(4). 377–381. 12 indexed citations
11.
Ford‐Hutchinson, A. W., M.A. Bray, Fiona Cunningham, E. M. Davidson, & M. J. H. Smith. (1981). Isomers of leukotriene B4 possess different biological potencies. Prostaglandins. 21(1). 143–152. 68 indexed citations
12.
Ford‐Hutchinson, A W, M.A. Bray, Michael Shipley, Mira Doig, & M. J. H. Smith. (1980). Leukotriene B: A potent mediator of leucocyte function released from polymorphonuclear leucocytes. International Journal of Immunopharmacology. 2(3). 232–232. 13 indexed citations
13.
Ford‐Hutchinson, A. W., M.A. Bray, & M. J. H. Smith. (1980). Lipoxygenase products and the polymorphonuclear leucocyte. Inflammation Research. 10(6). 548–550. 17 indexed citations
14.
Bray, M.A.. (1980). Prostaglandins: fine tuning the immune system?. Immunology Today. 1(3). 65–69. 31 indexed citations
15.
Bray, M.A. & M. J. H. Smith. (1980). Effects on human lymphocyte transformation of drugs inhibiting lipoxygenase enzyme pathways of arachidonic acid metabolism. International Journal of Immunopharmacology. 2(3). 256–256. 1 indexed citations
16.
Bray, M.A. & Marcelo De Franco. (1978). Prostaglandins and Inflammatory Cell Movement <i>in vitro</i>. International Archives of Allergy and Immunology. 56(6). 500–506. 8 indexed citations
17.
Bray, M.A., et al.. (1976). Heterogeneity of guinea-pig lymphokines revealed by parallel bioassay. Clinical & Experimental Immunology. 23(2). 333–902. 8 indexed citations
18.
Gordon, Duncan A., M.A. Bray, & John E. Morley. (1976). Control of lymphokine secretion by prostaglandins. Nature. 262(5567). 401–402. 334 indexed citations
19.
Bray, M.A., et al.. (1974). Role of prostaglandins in reactions of cellular immunity.. British Journal of Pharmacology. 52(3). 453. 46 indexed citations
20.
Bray, M.A., et al.. (1974). Proceedings: Role of prostaglandins in reactions of cellular immunity.. PubMed. 52(3). 453P–453P. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026